The Indian generics sector has been struggling lately with quality issues and increased competition in export markets.
from Forbes Real Time https://www.forbes.com/sites/naazneenkarmali/2017/10/04/indias-100-richest-2017-bitter-pill-to-swallow-for-indias-pharma-companies/
via IFTTT
No comments:
Post a Comment